These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 20043018)
1. 2009 in reflection. Nat Rev Drug Discov; 2010 Jan; 9(1):5-8. PubMed ID: 20043018 [No Abstract] [Full Text] [Related]
2. Comparative effectiveness research: critically intertwined with health care reform and the future of biomedical innovation. Murray RK; McElwee NE Arch Intern Med; 2010 Apr; 170(7):596-9. PubMed ID: 20386002 [No Abstract] [Full Text] [Related]
3. Opportunities for alliances between industry and pharmacy. Rosenberg GB Am J Hosp Pharm; 1994 Dec; 51(24):3061-5. PubMed ID: 7856627 [No Abstract] [Full Text] [Related]
4. Escaping the pincer. Nat Rev Drug Discov; 2009 Dec; 8(12):915. PubMed ID: 19967796 [No Abstract] [Full Text] [Related]
5. Does size matter in R&D productivity? If not, what does? Ringel M; Tollman P; Hersch G; Schulze U Nat Rev Drug Discov; 2013 Dec; 12(12):901-2. PubMed ID: 24136396 [No Abstract] [Full Text] [Related]
7. Pharmaceutical industry. Lewis L State Health Care Am; 1994; ():23-7. PubMed ID: 10133845 [TBL] [Abstract][Full Text] [Related]
8. The (possible) impact of comparative effectiveness research on pharmaceutical industry decision making. Chalkidou K Clin Pharmacol Ther; 2010 Mar; 87(3):264-6. PubMed ID: 20160745 [TBL] [Abstract][Full Text] [Related]
9. How will drug and device makers fare under Clinton's reform plan? Blankenau R Mater Manag Health Care; 1993 Nov; 2(11):18, 20. PubMed ID: 10129563 [No Abstract] [Full Text] [Related]
10. GlaxoSmithKline pushes its labs towards 'biotech' future. Adam D Nature; 2001 Mar; 410(6824):5. PubMed ID: 11242002 [No Abstract] [Full Text] [Related]
12. The future research agenda. A view from the pharmaceutical industry. Barr C Pharmacoeconomics; 1994; 6 Suppl 1():61-2. PubMed ID: 10155587 [TBL] [Abstract][Full Text] [Related]
13. Back to the future. Offit P Expert Rev Vaccines; 2004 Apr; 3(2):107-8. PubMed ID: 15056035 [No Abstract] [Full Text] [Related]
14. Looking outward: content as a service starts to make sense. Sherlock A Drug Discov Today; 2013 Jan; 18(1-2):1-3. PubMed ID: 23041498 [No Abstract] [Full Text] [Related]
15. Models for open innovation in the pharmaceutical industry. Schuhmacher A; Germann PG; Trill H; Gassmann O Drug Discov Today; 2013 Dec; 18(23-24):1133-7. PubMed ID: 23892183 [TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness research stalls in the USA. Webster PC Lancet; 2010 Jan; 375(9712):361-2. PubMed ID: 20135825 [No Abstract] [Full Text] [Related]
18. An audience with...Marc Cluzel. Cluzel M Nat Rev Drug Discov; 2010 Jan; 9(1):14. PubMed ID: 20043024 [TBL] [Abstract][Full Text] [Related]
19. Swimming upstream: comparative effectiveness research in the US. Greene JA Pharmacoeconomics; 2009; 27(12):979-82. PubMed ID: 19908922 [No Abstract] [Full Text] [Related]
20. Interview: comparative effectiveness research and challenges to healthcare reform in the Middle East and USA. Younis MZ J Comp Eff Res; 2013 May; 2(3):223-5. PubMed ID: 24236620 [No Abstract] [Full Text] [Related] [Next] [New Search]